These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16320923)

  • 1. Abnormal hemodynamic responses to exercise as a marker of end-organ damage in the "high-normal" blood pressure state.
    Grassi G
    Ital Heart J; 2005 Nov; 6(11):893-4. PubMed ID: 16320923
    [No Abstract]   [Full Text] [Related]  

  • 2. Twenty-four-hour mean heart rate and likelihood of left ventricular hypertrophy.
    Palmieri V
    Am J Hypertens; 2006 Feb; 19(2):178. PubMed ID: 16448888
    [No Abstract]   [Full Text] [Related]  

  • 3. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension.
    Stergiou GS; Argyraki KK; Moyssakis I; Mastorantonakis SE; Achimastos AD; Karamanos VG; Roussias LG
    Am J Hypertens; 2007 Jun; 20(6):616-21. PubMed ID: 17531917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epicardial coronary vessels and coronary microcirculation in pressure overload hypertrophy: a complex interaction.
    Galderisi M
    Am J Hypertens; 2007 Mar; 20(3):285-6. PubMed ID: 17324741
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in structure and function of the left ventricle in the hypertension syndrome.
    Papademetriou V; Kokkinos PF
    J Cardiovasc Risk; 1997 Aug; 4(4):261-5. PubMed ID: 9477203
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of preclinical target organ damage in hypertesion: left ventricular hypertrophy.
    Rosei EA
    Blood Press; 2003; 12(3):183-4. PubMed ID: 12875482
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular permeability, blood pressure, and organ damage in primary hypertension.
    Viazzi F; Leoncini G; Ratto E; Parodi A; Falqui V; Conti N; Tomolillo C; Ravera G; Deferrari G; Pontremoli R
    Hypertens Res; 2008 May; 31(5):873-9. PubMed ID: 18712042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population.
    Kulah E; Dursun A; Aktunc E; Acikgoz S; Aydin M; Can M; Dursun A
    Blood Press Monit; 2007 Aug; 12(4):207-13. PubMed ID: 17625392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of autonomic modulation: more than just blood pressure.
    Zile MR; Little WC
    J Am Coll Cardiol; 2012 Mar; 59(10):910-2. PubMed ID: 22381426
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertension and left ventricular hypertrophy in the CAPD patient.
    Amann K; Mandelbaum A; Schwarz U; Ritz E
    Kidney Int Suppl; 1996 Nov; 56():S37-40. PubMed ID: 8914052
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent ventricular repolarization markers in resistant hypertension: are they different from the traditional QT interval?
    Salles GF; Cardoso CR; Leocadio SM; Muxfeldt ES
    Am J Hypertens; 2008 Jan; 21(1):47-53. PubMed ID: 18091743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy.
    Kozakova M; Paterni M; Bartolomucci F; Morizzo C; Rossi G; Galetta F; Palombo C
    Am J Hypertens; 2007 Mar; 20(3):279-84. PubMed ID: 17324740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular repolarization in hypertension: beyond Bazett.
    Passino C; Emdin M
    Am J Hypertens; 2008 Jan; 21(1):9. PubMed ID: 18091736
    [No Abstract]   [Full Text] [Related]  

  • 15. Twenty-four-hour heart rate and blood pressure are additive markers of left ventricular mass in hypertensive subjects.
    Zakopoulos NA; Ikonomidis I; Vemmos KN; Manios E; Spiliopoulou I; Tsivgoulis G; Spengos K; Psaltopoulou D; Mavrikakis M; Moulopoulos SD
    Am J Hypertens; 2006 Feb; 19(2):170-7. PubMed ID: 16448887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of detection of hypertensive reaction to physical loading in patients with or without left ventricular hypertrophy and arterial hypertension].
    Ivanov AP; Saĭeda EA; El'gardt IA; Sdobniakova NS
    Klin Med (Mosk); 2009; 87(7):24-6. PubMed ID: 19705786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood pressure components and target organ damage].
    Schillaci G; Reboldi G; Vaudo G
    Ital Heart J Suppl; 2001 Apr; 2(4):363-8. PubMed ID: 19397008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home BP for assessing haemodialysis hypertension.
    Agarwal R
    Nephrol Dial Transplant; 2007 Oct; 22(10):3089-90; author reply 3090. PubMed ID: 17636055
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies.
    Su DF
    Curr Opin Cardiol; 2006 Sep; 21(5):486-91. PubMed ID: 16900013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure load, vascular permeability and target organ damage in primary hypertension.
    Falqui V; Viazzi F; Leoncini G; Ratto E; Parodi A; Conti N; Tomolillo C; Deferrari G; Pontremoli R
    J Nephrol; 2007; 20 Suppl 12():S63-7. PubMed ID: 18050146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.